Role of nanotechnology in diagnosis and disease control with a focus on COVID-19 and future perspectives

ABSTRACT

Recently the Coronavirus disease-2019 (COVID-19) has affected the public throughout the world and has become a severe risk to human being. COVID-19 is a growing communicable disease and has caused major mortality and morbidity beside socioeconomic damage. No successful treatment has been accepted for this type of pandemic disease. In this situation nanotechnology has been very much helpful in preclinical studies for different types of pathogens of diseases like respiratory viruses, herpes virus, human papillomavirus, and HIV. Therefore nanoparticles have been of interest for the management of COVID-19 disease due to their small and distinctive properties, like simple preparation, low cost, easy modification, and appropriate size. For COVID-19 disease, nanotechnology-based management comprises the development of tools for exact, speedy, and responsive diagnosis, the manufacture of efficient disinfectants, and the delivery of vaccines and antiviral drugs into the human body. In this review the main object is to recommend some approaches to design and produce successful diagnostic and beneficial drugs against COVID-19 with the help of nanotechnology. This review mainly focuses on COVID-19 prevention, diagnosis, and therapy. Molecular nanotechnology is a provisional field of nanotechnology investigating the opportunity of industrial molecular assembly machinery that can rearrange substances at a molecular or atomic level. Nanomedicine is the application of these nanorobots, introduced into the body, to identify viruses. Molecular nanotechnology is extremely hypothetical, anticipating what innovations nanotechnology may yield and the programs offered for the investigation of COVID-19. © 2023 Elsevier Inc. All rights reserved.